GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » Cyclically Adjusted Price-to-FCF

Zentiva (BSE:SCD) Cyclically Adjusted Price-to-FCF : 113.00 (As of Jun. 05, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Zentiva's current share price is lei4.52. Zentiva's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was lei0.04. Zentiva's Cyclically Adjusted Price-to-FCF for today is 113.00.

The historical rank and industry rank for Zentiva's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSE:SCD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 30.33   Med: 59   Max: 113
Current: 109.51

During the past years, Zentiva's highest Cyclically Adjusted Price-to-FCF was 113.00. The lowest was 30.33. And the median was 59.00.

BSE:SCD's Cyclically Adjusted Price-to-FCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 31.58 vs BSE:SCD: 109.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zentiva's adjusted free cash flow per share data for the three months ended in Mar. 2025 was lei0.021. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is lei0.04 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zentiva Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Zentiva's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva Cyclically Adjusted Price-to-FCF Chart

Zentiva Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 37.61 40.27 83.34 116.20

Zentiva Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.14 82.31 107.11 116.20 109.51

Competitive Comparison of Zentiva's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zentiva's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentiva's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zentiva's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zentiva's Cyclically Adjusted Price-to-FCF falls into.


;
;

Zentiva Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Zentiva's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=4.52/0.04
=113.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentiva's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zentiva's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.021/134.9266*134.9266
=0.021

Current CPI (Mar. 2025) = 134.9266.

Zentiva Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.000 105.290 0.000
201806 0.000 106.317 0.000
201809 0.000 106.507 0.000
201812 0.000 105.998 0.000
201903 -0.013 107.251 -0.016
201906 -0.002 108.070 -0.002
201909 -0.066 108.329 -0.082
201912 0.000 108.420 0.000
202003 0.015 108.902 0.019
202006 0.035 108.767 0.043
202009 0.010 109.815 0.012
202012 -0.034 109.897 -0.042
202103 -0.085 111.754 -0.103
202106 0.078 114.631 0.092
202109 -0.027 115.734 -0.031
202112 0.275 117.630 0.315
202203 -0.008 121.301 -0.009
202206 -0.005 125.017 -0.005
202209 0.030 125.227 0.032
202212 -0.026 125.222 -0.028
202303 -0.018 127.348 -0.019
202306 -0.009 128.729 -0.009
202309 -0.016 129.860 -0.017
202312 0.023 129.419 0.024
202403 0.040 131.776 0.041
202406 0.010 132.554 0.010
202409 -0.013 133.029 -0.013
202412 0.015 133.157 0.015
202503 0.021 134.927 0.021

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zentiva  (BSE:SCD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Zentiva Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Zentiva's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentiva Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.

Zentiva Headlines

From GuruFocus